BackTable Urology

Could a team-based approach accelerate adoption of new bladder cancer therapies? In this episode of BackTable Urology, Dr. Amy Lukenbaugh (@AmyLuckenbaugh), Dr. Bogdana Schmidt (@BogdanaSchmidt), and Meredith Donahue NP outline the process of co-managing intravesical therapy clinics. The discussion covers multidisciplinary roles, protocol development, and the impact on patient outcomes. Watch the full episode here: backtable.com/shows/urology/… This podcast is supported by Johnson & Johnson. #URO306 #TB63 #BladderCancer #IntravesicalTherapy #TeamBasedCare

Surgery is the definitive treatment for adult acquired buried penis, but success takes a powerhouse team. This episode of BackTable Urology highlights the need for multidisciplinary care teams and recent advancements in treatment of adult buried penis, featuring Dr. Geourge Koch and Dr. Paul Rusilko. This episode also features Dr. Rusilko’s novel W-plasty surgical technique, making this a must-listen for those interested in reconstruction! Listen to this episode and more on the BackTable app! #Urology #GURS #URO319 #Reconstruction na2.hubs.ly/H06WJhX0

This was one of my favorite discussions on @_backtableUro and it’s clear by the number of messages and texts that I’ve gotten about it, others feel the same! @UroDrBen @UrologyUS Have a listen and let us know what you think on the new @_backtable app 👉🏽 apps.apple.com/us/app/backtab…

The future of OAB treatment is choosing the right device for the right patient. @KennethMPeters1 and Dr. Tracey Wilson join @JannahTMD to discuss neuromodulation, patient selection, implementation, and equitable access in OAB care. This podcast is supported by @sufuorg. 🎧 na2.hubs.ly/H06PjpH0 #URO318 #SUFU #URPS #Neuromodulation #OAB

How do you approach robotic reconstruction for vesicourethral anastomosis stenosis? This week's Case Highlight explores robotic vesicourethral anastomosis stenosis excision and primary anastomosis with a rectus flap with Dr. Ziho Lee (@ZLeeGU) and Dr. George Koch (@_KochDoc) Explore more clinical cases and discussions in the BackTable App: na2.hubs.ly/H06KVNb0 #Urology #ReconstructiveUrology #RoboticSurgery #MedEd

As focal therapy continues to gain traction, how should urologists think about incorporating it into practice? In this episode of BackTable Urology, Dr. Tiwa Akinsola (@Akinsola_MD) sits down with Dr. George Schade to explore where focal therapy fits in modern prostate cancer care. They discuss patient selection, HIFU and IRE, surveillance after treatment, the latest clinical evidence, and the real-world challenges of bringing focal therapy into practice. Whether you're already offering focal therapy or interested in better understanding its role in localized prostate cancer, this conversation offers a thoughtful look at where focal therapy stands today and where it's headed next. Listen here: na2.hubs.ly/H06Ky8F0 #URO317 #UrologicOncology #ProstateCancer #AUA #FocalTherapy

In this episode of @_backtableUro Urology, Robert Brannigan, MD (@rebrannigan), joins guest host Catherine Nam, MD (@CatherineSNamMD), to unpack the 2024 AUA/ASRM Male Infertility Guideline update and discuss how the field is evolving beyond basic semen analysis. @AmerUrological backtable.com/shows/urology/…

Germline BRCA2 in mHSPC — how much should it change frontline therapy? Joined @TDorffOnc and Evan Yu on @_backtableUro to talk PARP sequencing, cascade testing, and the real-world tradeoffs between efficacy and long-term risk. 🎧

How does a germline BRCA2 mutation affect frontline therapy for metastatic hormone-sensitive prostate cancer? In this episode of BackTable Urology, Dr. Tonya Dorff, Dr. Evan Yu, and Dr. Alan Tan explore the impact of genetic findings on treatment intensity, cascade testing, and shared decision-making. The discussion covers PARP inhibitor use, family counseling, and balancing efficacy with long-term risks. Watch the full episode here: backtable.com/shows/urology/… This podcast is supported by an educational grant from Pfizer. #URO307 #ProstateCancer #GeneticTesting #SomaticTesting

Community bladder cancer care is evolving, and so are the challenges of delivering it. @Uro_gadz joins @ruchikatalwarmd to discuss implementing new NMIBC therapies, expanding clinical trial access, and the practical realities of bringing innovative bladder cancer care into community practice. 🎧 na2.hubs.ly/H06Gk500 #URO316 #SUO #UrologicOncology #NMIBC

How do chemoradiation, the TIP regimen, and the Hercules regimen fit into the management of penile cancer? This week's Case Highlight explores treatment considerations for penile cancer with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton. Explore more clinical cases and discussions in the BackTable App 📲: backtable.com/shows/urology/… #Urology #UrologicOncology #PenileCancer #MedEd

“Private equity is often painted with a singular brush, when I think there are dozens of different stories that are happening.” This week on BackTable Urology, host Dr. Ruchika Talwar discusses the role of private equity in urologic practices with Dr. Benjamin Lowentritt, resulting in an engaging conversation on the benefits, drawbacks, and realities of private equity in urology today. Utilize the BackTable app to access the full episode and more!  #Urology #PrivateEquity #URO315 #MedEd na2.hubs.ly/H06z-X40

@alantanmd @DrRanaMcKay @EAntonarakis @neerajaiims @AzadOncology @CParkMD @APCCC_Lugano @TDorffOnc @DrChoueiri @Daniel_J_George @DrYukselUrun @VUMCDiscoveries 👏👏👏

Our final episode is out! We recorded 3 podcasts addressing PARP in prostate cancer. You’ll definitely want to listen to this one with @DrRanaMcKay UC San Diego Moores Cancer Center and @EAntonarakis Masonic Cancer Center, University of Minnesota I really enjoyed this one. One recurring theme, germline and somatic testing must be done to optimally manage our patients with advanced prostate cancer. Also nice discussion on the transition from HSPC/CRPC to APMS/APMR in PCWG4. Watch the full episode here: youtu.be/CMXtFQPp35c?is… Get app and Listen here: na2.hubs.ly/H06x3F60

Why does genetic testing matter at every stage of prostate cancer care? In this episode of BackTable Urology, Dr. Tonya Dorff, Dr. Evan Yu, and Dr. Alan Tan address the gap between recommendations and reality. They share tips for successful patient education and strategies to increase access and test utilization. Watch the full episode here: backtable.com/shows/urology/… This podcast is supported by an educational grant from Pfizer. #URO307 #ProstateCancer #GeneticTesting #SomaticTesting

Listen up - literally! 🎧The fantastic @_backtableUro podcast recently featured our chair @KGUromd in conversation with @RuchikaTalwarMD discussing how advanced imaging influences decisions for radical prostatectomy. Listen here: backtable.com/shows/urology/…

With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for advanced prostate cancer? In this episode of BackTable Urology, we cover PARP inhibitor combination therapy, highlighting key takeaways from recent studies like PROpel, MAGNITUDE, TALAPRO-2, and AMPLITUDE, and reflect on insights from #APCCC2026.  Listen here: na2.hubs.ly/H06x3F60 This podcast is supported by an educational grant from Pfizer. #URO314 #TB71 #Urology #ProstateCancer #MedEd

Last month, we welcomed physician contributors, podcast guests, and industry partners to our new BackTable HQ and recording studio in San Diego! Here's a look behind the scenes at the conversations and community that help make each episode possible. 🎙️

Why is early identification of anemia crucial for mCRPC patients on PARP inhibitors? Dr. Alan Tan, Dr. Neeraj Agarwal and Dr. Arun Azad highlight the importance of diagnostic workups and tailored interventions. Their experience shows how careful management minimizes treatment interruptions. Watch the full episode here: backtable.com/shows/urology/… This podcast is supported by Pfizer. #URO303 #TB60 #Cancer #ProstateCancer #PARPInhibitor